Participated · Equity · Aug 2026

Incorporated in 2000 and based in Goa, Molbio Diagnostics develops and manufactures the Truenat point-of-care PCR platform and test kits for molecular diagnosis across more than 30 diseases including tuberculosis, COVID, HIV, HPV and hepatitis B and C. Its battery-operated Truenat platform is patented in over 100 countries and is designed for deployment in resource-limited settings to enable decentralized diagnosis within an hour. The company operates six manufacturing facilities in India (two in Goa, two in Bengaluru, and one each in Visakhapatnam and Pune) with an installed capacity of 5,400 devices per annum and 3.9 crore Truenat test kits annually as of March 31, 2026. Financially, Molbio reported revenue from operations of ₹1,445 crore and profit of ₹164 crore for fiscal 2026. The company intends to expand R&D and manufacturing capacity using proceeds from its IPO, including funds earmarked for a Centre of Excellence, additional infrastructure and new plant and machinery. Its shares are proposed to be listed on the BSE and NSE on August 17, 2026.

Participated · Series C · Jul 2026

PixVerse develops generative video models including a V-Series for consumer/API use, a C-Series for professional film and commercial workflows, and an R-Series of world models for game development and world building. Its tool can generate videos up to 4K resolution with audio baked in, and the company reports over 150 million registered users and more than 15 million monthly active users. The startup offers image-to-video generation at a cited competitive rate of $4.80 per minute. PixVerse released its R-Series world models earlier this year and plans to launch a new V-Series model and a new world-model version within the year. The company has about 150 employees across offices in Singapore, Beijing, and Shanghai and has commercial relationships including a deployment deal with investor Alibaba.

Participated · Equity · Jun 2026

Turtlemint is positioned as an insurtech firm preparing to go public via an IPO scheduled to open on June 19, 2026. As part of the IPO process the company secured ₹397.20 crore from anchor investors at a price of ₹152 per share. The planned IPO aims to raise total proceeds of ₹883 crore, which includes an offer-for-sale component of ₹221 crore. The anchor allocation comprised 26.13 million equity shares, with a substantial portion (11.11 million shares) allotted to domestic mutual fund schemes. The company has engaged ICICI Securities, Jefferies India, JM Financial and Motilal Oswal as book-running lead managers for the offering. No additional operational metrics or financial performance figures were disclosed in the article.

Led · Equity · Mar 2026

Founded in 2020, Rebellions designs AI chips focused on inference workloads and outsources manufacturing. The company has released AI infrastructure products named RebelRack and RebelPOD, described as production-ready and scalable inference units. Rebellions has raised $850 million to date and is valued at approximately $2.34 billion after the latest $400 million pre-IPO round. It closed a $124 million Series B in 2024 and a $250 million Series C in November prior to this round. The startup is pursuing aggressive international expansion, having established entities in the U.S., Japan, Saudi Arabia, and Taiwan and aiming to build partner ecosystems with cloud providers, government agencies, telecom operators, and Neoclouds. Management has indicated the company is preparing for an IPO later this year while scaling commercial deployments of its inference infrastructure.

Participated · Series B · Mar 2026

Genspark builds an agentic workplace software platform designed to automate workflows and boost productivity in professional environments. The company was founded by Wen Sang. In June 2026 it raised a $100 million Series B extension, increasing its total funding to more than $645 million. That financing set a post-money valuation of $2.6 billion, a 63% valuation increase over three months. Reported participants in the extension included Sozo Ventures, UpHonest Capital, and Mirae Asset. The company did not disclose specific plans for how the proceeds will be used.